Literature DB >> 8739852

Regulation of hematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors.

J Golay1, L Basilico, L Loffarelli, S Songia, V Broccoli, M Introna.   

Abstract

The myb family of genes include the virally encoded v-myb oncogene, its normal cellular equivalent c-myb and two related members called A-myb and B-myb. They are all transcription factors that recognize the same DNA sequence (PyAACG/TG) and are all involved in the regulation of proliferation and differentiation in different cell types, including hematopoietic cells. C-myb is most highly expressed in hematopoietic cells and its oncogenic activation leads to transformation of these cells. Several lines of evidence have demonstrated that c-myb regulates both the proliferation and differentiation of hematopoietic cells of different lineages. The mechanisms of action of c-myb and v-myb are becoming clearer, mostly through the study of the different genes that are regulated by these transcription factors and the cofactors with which c-myb and v-myb co-operate. More recently the biological and biochemical functions of the B-myb and A-myb gene products have been investigated. Evidence for the function of the different members of the myb family in relation to hematopoietic proliferation and differentiation is presented, and the different roles of the myb genes are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739852     DOI: 10.1007/bf02644770

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  7 in total

1.  Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.

Authors:  V Facchinetti; L Loffarelli; S Schreek; M Oelgeschläger; B Lüscher; M Introna; J Golay
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

2.  Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.

Authors:  J Bies; V Nazarov; L Wolff
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein.

Authors:  M A Colgin; J K Nyborg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

4.  Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma.

Authors:  Qinghua Xu; Cong Tan; Shujuan Ni; Qifeng Wang; Fei Wu; Fang Liu; Xun Ye; Xia Meng; Weiqi Sheng; Xiang Du
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

5.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.

Authors:  Ruli Gao; Chunxia Cao; Min Zhang; Maria-Cecilia Lopez; Yuanqing Yan; Zirong Chen; Yoshitsugu Mitani; Li Zhang; Maria Zajac-Kaye; Bin Liu; Lizi Wu; Rolf Renne; Henry V Baker; Adel El-Naggar; Frederic J Kaye
Journal:  Oncotarget       Date:  2014-12-30

6.  Machine learning-based classification of diffuse large B-cell lymphoma patients by eight gene expression profiles.

Authors:  Shuangtao Zhao; Xiaoli Dong; Wenzhi Shen; Zhen Ye; Rong Xiang
Journal:  Cancer Med       Date:  2016-02-11       Impact factor: 4.452

7.  The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma.

Authors:  Shuangtao Zhao; Shuangsang Fang; Yanhua Liu; Xixi Li; Shengyou Liao; Jinwen Chen; Jingjia Liu; Lianhe Zhao; Hui Li; Wei Zhou; Wenzhi Shen; Xiaoli Dong; Rong Xiang; Luhua Wang; Yi Zhao
Journal:  Oncotarget       Date:  2017-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.